Global
Liver Diseases Therapeutics Market: Snapshot
The
global market for liver diseases therapeutics is witnessing
increasing traction globally owing to factors such as the rapid rise
in the world’s population of geriatrics, rising prevalence of liver
diseases, and the presence of vast unmet needs in the field of liver
cancer treatment. The liver disease therapeutics market is also
driven by the increased focus of developing economies on undertaking
vaccination drives to reduce the occurrence of chronic diseases. The
large number of highly anticipated and potentially strong and
effective liver disease drugs presently undergoing clinical trials or
in the pipeline is also expected to lead to promising growth
opportunities for the global liver disease therapeutics market.
Transparency
Market Research states that the global liver diseases market will
witness vast developments in the next few years as pharmaceutical
companies continue to invest vast funds on the development of new
drug varieties and newer technologies such as nanotechnology become
increasingly accessible. As a result, the global liver diseases
therapeutics market will exhibit a healthy 8.60% CAGR from 2012
through 2018, rising from a valuation of US$6.5 bn in 2011 to US$10.9
bn by 2018.
Download
Complete PDF
Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=799
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=799
Emerging
Economies to Provide Lucrative Growth Opportunities
High
incidence of liver diseases across emerging economies in regions such
as Asia Pacific, Latin America, and Eastern Europe is a leading
factor bolstering the growth prospects of the liver diseases
therapeutics market in these regions. It is estimated that these
regions and the development of the market across them will be a key
determinant of the growth of the global liver diseases therapeutics
market.
To
exploit the vast growth opportunities across these regions, companies
such as Novartis and GSK are establishing their operations across
countries such as China and India to begin a sustainable and parallel
source of revenue generation. Many other pharmaceutical companies are
also establishing research laboratories and R&D facilities across
these regions and the number is expected to continue to rise in the
next few years.
The
global liver diseases therapeutics market features an oligopolistic
competitive landscape and the top five vendors collectively account
for a massive chunk of the overall market. The market exhibits very
high entry barriers for new vendors owing to capital intensive drug
development and research activities and strict FDA norms regarding
drug approval. Some of the key vendors in the market are
GlaxoSmithKline Pharmaceuticals Limited, Crucell, Pfizer, Merck &
Co., Gilead Science Inc., Astellas Pharma Inc., Abbot Laboratories,
Novartis, Bristol-Myers Squibb, and Roche.
Browse
Full Research
Report:
http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html
http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html
About
Us
Transparency
Market Research (TMR) is a market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We have an
experienced team of Analysts, Researchers, and Consultants, who us e
proprietary data sources and various tools and techniques to gather,
and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to
sustain a competitive edge.
Each
TMR Syndicated Research report covers a different sector – such as
pharmaceuticals, chemical, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
our syndicated reports thrive to provide clients to serve their
overall research requirement.
Contact
Transparency
Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
No comments:
Post a Comment